Kristopher D. Brown

kristopher-brown

Kristopher D. Brown

Partner

New York | 1095 Avenue of the Americas, New York, NY 10036-6797
+1 212 698 3679 | +1 212 698 3599

| vCard | PDF

Kristopher D. Brown negotiates and structures private equity and venture capital financing transactions. He also advises on corporate and transactional matters for numerous financial and corporate strategic investors as well as emerging growth companies in the healthcare, life sciences, financial and information technology, electronics, energy and telecommunications industries.

Mr. Brown also has experience in the full range of complex commercial transactions, including mergers and acquisitions, divestitures, public offerings of both equity and debt securities, licensing transactions, the formation of investment partnerships, and the creation of strategic and collaborative alliances and joint ventures. Over the course of his more than 20 year career, Mr. Brown has advised on more than 250 transactions in the life sciences sector alone. In addition, he advises investors, management executives, and boards of directors on governance and regulation issues and securities laws.

Mr. Brown is listed as a "Life Sciences Star" and a "US Transactional Rising Star" by LMG Life Sciences and has been listed as a recommended lawyer for life sciences and capital markets: equity and global offerings by The Legal 500, where he was cited as being “highly skilled and committed” and noted for the “strength of his client relationships.” In addition, he has advised and led teams on award-winning life sciences deals, including Johnson and Johnson UK Treasury Company Limited as lead investor of a Series B financing of Grail, Inc., which was named LMG Life Sciences 2017 "Impact Deal of the Year"; Forward Pharma A/S’s IPO on Nasdaq in the US, which won M&A Advisor’s “Healthcare/Life Sciences Sector Deal of the Year” award; Johnson & Johnson’s partnership with Google Life Sciences to innovate advanced surgical robots, which won LMG’s "2015 Collaboration Deal of the Year"; AM-Pharma’s sale of a minority interest in the company to Pfizer Inc. and related option payment, which was a finalist for the 2015 Scrip Awards; and Zealand Pharma’s securitization of certain royalty rights under its license agreement with Sanofi-Aventis Deutschland GmbH, which was also a finalist for the 2015 Scrip Awards. In addition, Mr. Brown was an integral member of the global team of Dechert lawyers that advised Lazada on the US$1 billion sale of a controlling stake in the company to Alibaba, which was named M&A Deal of the Year: Southeast Asia by Asia Legal Awards.

Mr. Brown is a member of the Entrepreneurs Council of the Partnership for the City of New York, and is also a member of the National Advisory Council for, and serves as the pro bono outside general counsel to DonorsChoose.org. He also serves as a Blueprint Health mentor and is a member of the Advisory Board of Venture for America and the Advisory Board of Lyfebulb.

Education
  • Brown University, A.B., 1989, magna cum laude, Phi Beta Kappa
  • Boston University School of Law, J.D., 1992, magna cum laude
Admissions
  • New York
  • Massachusetts
  • California
  • United States District Court for the District of Massachusetts
  • United States District Court for the Southern District of New York
Memberships
American Bar Association
Association of the Bar of the City of New York